These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3684174)

  • 41. Polymorphic acetylation of the antibacterials, sulfamethazine and dapsone, in South Indian subjects.
    Peters JH; Gordon GR; Karat AB
    Am J Trop Med Hyg; 1975 Jul; 24(4):641-8. PubMed ID: 1155699
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The acetylator phenotypes of Saudi Arabians with coronary arterial atheroma.
    Evans DA; Wicks J; Higgins J; Assisto M
    J Med Genet; 1991 Mar; 28(3):192-3. PubMed ID: 2051455
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening methods using sulfamethazine for determining acetylator phenotype.
    du Souich P; McLean AJ; Stoeckel K; Ohlendorf D; Gibaldi M
    Clin Pharmacol Ther; 1979 Dec; 26(6):757-65. PubMed ID: 498718
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acetylation phenotype and skin complexion.
    Rampen FH; van der Meeren HL; Stolk LM
    Acta Derm Venereol; 1986; 66(4):334-6. PubMed ID: 2430405
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison between serum isonicotinic acid hydrazide (INH) levels and urinary sulfadimidine (sulfamethazine) acetylation as predictors of INH acetylator status.
    Seth V; Seth SD; Beotra A; Singh U
    Dev Pharmacol Ther; 1988; 11(1):32-6. PubMed ID: 3383719
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatic acetylator phenotype in diabetes mellitus.
    Ladero JM; Arrojo A; de Salamanca RE; Gomez M; Cano F; Alfonso M
    Ann Clin Res; 1982 Aug; 14(4):187-9. PubMed ID: 7168549
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Acetylation polymorphism in lung cancer].
    Laredo Quesada JM; Jara Sánchez C; Benítez Rodríguez J; Fernández Gundín MJ; Vargas Castrillón E; Muñoz González JJ; Llerena Ruiz A; Cobaleda Polo J; Pérez-Manga G
    An Med Interna; 1991 Feb; 8(2):66-8. PubMed ID: 1893005
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A simplified micromethod for the determination of the acetylator phenotype.
    Hoo JJ; Hussein L; Goedde HW
    J Clin Chem Clin Biochem; 1977 Jun; 15(6):329-31. PubMed ID: 894203
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiple N-acetyltransferases and drug metabolism. Tissue distribution, characterization and significance of mammalian N-acetyltransferase.
    Hearse DJ; Weber WW
    Biochem J; 1973 Mar; 132(3):519-26. PubMed ID: 4724587
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of genetically homozygous rapid and slow acetylators of drugs and environmental carcinogens among established inbred rabbit strains.
    Hein DW; Smolen TN; Fox RR; Weber WW
    J Pharmacol Exp Ther; 1982 Oct; 223(1):40-4. PubMed ID: 7120125
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NAT2 slow acetylator genotype as an important modifier of breast cancer risk.
    Sillanpää P; Hirvonen A; Kataja V; Eskelinen M; Kosma VM; Uusitupa M; Vainio H; Mitrunen K
    Int J Cancer; 2005 Apr; 114(4):579-84. PubMed ID: 15609332
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An assessment of acetylator polymorphism and its relevance in Papua New Guinea.
    Hombhanje F
    P N G Med J; 1990 Jun; 33(2):107-10. PubMed ID: 2238823
    [TBL] [Abstract][Full Text] [Related]  

  • 53. N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women.
    Deitz AC; Zheng W; Leff MA; Gross M; Wen WQ; Doll MA; Xiao GH; Folsom AR; Hein DW
    Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):905-10. PubMed ID: 11008907
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acetylator phenotype in patients with lung carcinoma--a negative report.
    Burgess EJ; Trafford JA
    Eur J Respir Dis; 1985 Jul; 67(1):17-9. PubMed ID: 4054252
    [TBL] [Abstract][Full Text] [Related]  

  • 55. N-acetylation of drugs: search for INH acetylation polymorphism in baboons.
    Radtke HE; Brenner W; Weber WW
    Drug Metab Dispos; 1979; 7(3):194-5. PubMed ID: 38093
    [No Abstract]   [Full Text] [Related]  

  • 56. Polymorphic acetylation of sulphamethazine in man: acetylator phenotype in sicklers and non-sicklers.
    Jeyakumar LH; French MR
    Toxicol Lett; 1980 Sep; 6(4-5):263-5. PubMed ID: 7423555
    [TBL] [Abstract][Full Text] [Related]  

  • 57. N-acetylation and oxidative capacity in aged volunteers determined with sulfamethazine and antipyrine.
    Siegmund W; Franke G; Wulkow R; Hanke W; Thonack R
    Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):469-73. PubMed ID: 1813431
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Determination of the N-acetyltransferase phenotype in urothelial cancer patients and healthy controls].
    Sone M
    Hinyokika Kiyo; 1986 Aug; 32(8):1085-92. PubMed ID: 3788733
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clonazepam acetylation in fast and slow acetylators.
    Miller ME; Garland WA; Min BH; Ludwick BT; Ballard RH; Levy RH
    Clin Pharmacol Ther; 1981 Sep; 30(3):343-7. PubMed ID: 7273597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acetylation phenotype in colorectal carcinoma.
    Ilett KF; David BM; Detchon P; Castleden WM; Kwa R
    Cancer Res; 1987 Mar; 47(5):1466-9. PubMed ID: 3815349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.